Coherus Oncology CHRS
NASDAQ CHRS
$0.99 -0.08 (-7.48%)
At close: Oct 16, 2026 · 4:00 PM EDT

Coherus Oncology (CHRS) Price to Book (2014 - 2026)

Updated

Coherus Oncology's (CHRS) Price to Book stood at 3.55 in Q2 2026, up 402.0% from 0.71 a year earlier and up 7.2% from the prior quarter.

Analysis

Coherus Oncology (CHRS) Price to Book (2014 - 2026) Analysis & Trends

For FY2025, Coherus Oncology's Price to Book came in at 2.82.

  • Across earlier years, Price to Book came in at 12.56 in FY2021 (+180.1%).
  • The Q2 2026 figure is the highest quarterly Price to Book since Q1 2022.
  • Per Business Quant, the preceding three quarters came in at 3.31 (Q1 2026), 2.82 (Q4 2025) and 2.17 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Coherus Oncology 155.59 Mn -480.55 Mn 10.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.55
Mar 31, 2026 3.31
Dec 31, 2025 2.82
Sep 30, 2025 2.17
Jun 30, 2025 0.71
Mar 31, 2022 79.47
Dec 31, 2021 12.56
Sep 30, 2021 9.41
Jun 30, 2021 6.77
Mar 31, 2021 8.37
Dec 31, 2020 4.49
Sep 30, 2020 5.17
Jun 30, 2020 5.98
Mar 31, 2020 7.31
Dec 31, 2019 12.04
Sep 30, 2019 25.36
Sep 30, 2018 90.56
Jun 30, 2018 15.36
Dec 31, 2017 17.25
Sep 30, 2017 13.77
API Access

Coherus Oncology Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=CHRS&period=max&api_key=YOUR_API_KEY